Figure 7 | Scientific Reports

Figure 7

From: Identification of cuproptosis-related long noncoding RNA signature for predicting prognosis and immunotherapy response in bladder cancer

Figure 7

Principal Component Analysis and Tumor Mutation Burden. (A–D) 3D scatterplot of sample distribution between the low-risk and high-risk BC patients based on the entire gene expression profile, cuproptosis genes, cuproptosis-related lncRNAs, and the lncRNA profile of risk signature, respectively. (E,F) Waterfall diagram containing the top 15 genes with high mutation frequency in the low-risk and high-risk groups. (G) Tumor mutation burden for two groups. (H) Kaplan–Meier curves of OS for patients in high and low TMB subgroups. (I) Kaplan–Meier curve of OS for patients classified by TMB and risk signature.

Back to article page